A Novel Sequential Treatment of Palbociclib Enhances the Effect of Cisplatin in RB-Proficient Triple-Negative Breast Cancer
Yajing Huang(Tongji Hospital), Xingrui Li(Huazhong University of Science and Technology)
Cited by 0
Related Papers
<p>Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway</p>
|OncoTargets and Therapy|2019|75
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia
|JAMA Oncology|2017|48
Novel sequential treatment with palbociclib enhances the effect of cisplatin in RB-proficient triple-negative breast cancer
|Cancer Cell International|2020|21